IP Library Granted Patent US 10,590,388
Granted Patent B2
US 10,590,388 · App. 15/546,047 · Granted Mar 17, 2020

Cell culture method using bone marrow-like structure, and porous polyimide film for healing bone injury site

Inventors: Keisuke Ohta (Kurume, JP); Shingo Hirashima (Kurume, JP); Masahiko Hagihara (Ube, JP); Motohisa Shimizu (Ube, JP)
Assignees: UBE INDUSTRIES, LTD.; KURUME UNIVERSITY
C12N5/0669A61L27/18A61L27/3608A61L27/56C08J9/00C12N1/00C12N5/0647A61L2430/02C12N2501/14C12N2533/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,590,388
App. No.
15/546,047
Granted
Mar 17, 2020
Kind
B2
Abstract

The present invention relates to a method for culturing bone marrow cells, in which bone marrow cells are applied to a porous polyimide film and cultured. Moreover, the present invention relates to a porous polyimide film for healing a bone injury site.

Claims (20)

1. A method of healing a bone injury site,

including applying a porous polyimide film to an affected area of bone injury of a patient in need of healing the bone injury site,

wherein the porous polyimide film has a three-layer structure consisting of an A-surface layer having a plurality of pores, a B-surface layer having a plurality of pores, and a macro-void layer sandwiched between the two surface layers,

a mean pore size in the A-surface layer is smaller than a mean pore size in the B-surface layer, and

the macro-void layer has a partition bonded to the A-surface layer and the B-surface layer, and a plurality of macro-voids surrounded by the partition, the A-surface layer, and the B-surface layer,

wherein the bone injury is a fracture or bone loss,

wherein cells have not been supported on the porous polyimide film, or mammal-derived bone marrow cells have been supported on the porous polyimide film beforehand; and

wherein the A-surface layer of the porous polyimide film is applied to the affected area of bone injury of the patient.

2. The method according to claim 1 , wherein the bone injury is a fracture.

3. The method according to claim 1 , wherein the bone injury is bone loss.

4. The method according to claim 1 , including transplantation of the porous polyimide film into the body in such a manner that the porous polyimide film is in contact with an affected area of bone injury.

5. The method according to claim 1 , wherein the porous polyimide film is a porous polyimide film including a polyimide obtained from a tetracarboxylic dianhydride and a diamine.

6. The method according to claim 5 , wherein the porous polyimide film is a colored porous polyimide film obtained by forming a polyamic acid solution composition including a polyamic acid solution obtained from a tetracarboxylic dianhydride and a diamine, and a coloring precursor, and then heat treating it at 250° C. or higher.

7. The method according to claim 1 , including transplantation of the porous polyimide film into the body in such a manner that is in contact with the affected area of bone injury.

8. The method according to claim 1 , wherein the film thickness of the porous polyimide film is no greater than 100 micrometers.

9. The method according to claim 1 , wherein the surface of the porous polyimide film is treated by a step of modifying its physical properties.

10. The method according to claim 9 , wherein the step of modifying the physical properties of the surface of the porous polyimide film is selected from the group consisting of a step of alkali treatment of the surface of the porous polyimide film, a step of calcium treatment, a step of covering with a biocompatible material, and a combination of any of these steps.

11. The method according to claim 10 , wherein the biocompatible material is selected from the group consisting of collagen, fibronectin, laminin, polylysine, polylactide, polyglycolide, polycaprolactone, polyhydroxybutyrate, polylactide-co-caprolactone, polycarbonate, biodegradable polyurethane, polyether ester, polyesteramide, hydroxyapatite, collagen/β-TCP complex, and combinations of the foregoing.

12. The method according to claim 1 , wherein mammal-derived bone marrow cells have been supported on the porous polyimide film beforehand.

13. The method according to claim 1 , wherein cells have not been supported on the porous polyimide film.

Assignments (2)
CHANGE OF NAME Recorded Jul 14, 2023
From: UBE INDUSTRIES, LTD.
To: UBE CORPORATION
Reel/Frame 064275/0021 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2017
From: OHTA, KEISUKE; HIRASHIMA, SHINGO; HAGIHARA, MASAHIKO; SHIMIZU, MOTOHISA
To: UBE INDUSTRIES, LTD.; KURUME UNIVERSITY
Reel/Frame 043746/0072 →
Priority Claims (2)
JP 2015-012696 · Jan 26, 2015 · national
JP 2015-012743 · Jan 26, 2015 · national
Continuity (1)
Related Publication 20180148693A1 · May 31, 2018
Cited By (1)
US 12,383,246